Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Fosun Pharmaceutical

Explore full profile

Shanghai Fosun Pharmaceutical a leading healthcare company in China

Baoshan District, ChinaFounded 1994Biotech & Life Sciences
Valuation $11B Market cap · Aug/2026
Revenue $5.96B Latest reported FY
EBITDA $946M Latest reported FY

At a glance

Status
Listed
Founded
1994
Headquarters
Baoshan District, China
Listing
IPO 2012
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News Gland Pharma slips after ₹2,121 Cr block deal; Fosun Pharma likely seller Sep 4, 2026

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
25 countries with
team presence
🇨🇳 China82.5%
🇺🇸 United States5.1%
🇭🇰 Hong Kong2.5%
🇬🇧 United Kingdom1.6%
🇮🇳 India1.2%
Top 5 of 25 shown
Web traffic by country
28K monthly visits
across markets
🇨🇳 China53.2%
🇺🇸 United States10.4%
🇭🇰 Hong Kong8.2%
🏳️ Korea5.4%
🏳️ Republic of5.4%
Top 5 markets shown

Patents

Estimated portfolio value
$166M

1,781 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Shanghai Fosun Pharmaceutical was the backer or acquirer, 2009–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

27 deals across Shanghai Fosun Pharmaceutical's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Shanghai Fosun Pharmaceutical deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Shanghai Fosun Pharmaceutical's portfolio, mapped.

        Stage
        Period
        27 of 27 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Shanghai Fosun Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Shanghai Fosun Pharmaceutical on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles